URGN · Insider trading · 13F holders · Congress trades
UroGen Pharma Ltd. (URGN)
Who is buying and selling URGN: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 17
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $3.0M
- Congress trades, 12 months
- 0
URGN at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 3 URGN insiders filed 4 sales worth $3.0M on SEC Form 4, and no open-market purchases.
- 17 13F filers hold URGN among their 50 largest positions, worth $612.1M combined. The biggest bets by portfolio weight are Acorn Capital Advisors, LLC (16.8%), Silverarc Capital Management, LLC (5.3%) and Kynam Capital Management, LP (5.0%). In their latest 13Fs, 1 manager opened a new position and 2 added to one.
- No member of Congress has disclosed a trade in URGN.
- URGN last closed at $33.48 on Oct 29, 2026.
URGN insider trading
Between Aug 1, 2026 and Oct 29, 2026, 3 URGN insiders filed 4 sales worth $3.0M on SEC Form 4, and no open-market purchases.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Oct 9, 2026 | Degnan Chris | Chief Financial Officer | Sale | 2,202 | $36.69 | $81K | SEC |
| Sep 9, 2026 | Smith Jason Drew | General Counsel | Sale | 1,519 | $42.54 | $65K | SEC |
| Sep 9, 2026 | Schoenberg Mark | Chief Medical Officer | Sale | 871 | $42.92 | $37K | SEC |
| Aug 24, 2026 | Schoenberg Mark | Chief Medical Officer | Sale | 60,677 | $47.05 | $2.9M | SEC |
Who owns URGN? Hedge funds and superinvestors
17 13F filers hold URGN among their 50 largest positions, worth $612.1M combined. The biggest bets by portfolio weight are Acorn Capital Advisors, LLC (16.8%), Silverarc Capital Management, LLC (5.3%) and Kynam Capital Management, LP (5.0%). In their latest 13Fs, 1 manager opened a new position and 2 added to one.
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Rtw Investments, LPHedge fund | 1.4% | $167.2M | 4,543,895 | +0.0% shares | Q2 2026 |
| Kynam Capital Management, LPHedge fund | 5.0% | $89.6M | 2,434,207 | +8.3% shares | Q2 2026 |
| Jefferies Financial Group Inc.Broker-dealer | 0.8% | $80.9M | 2,199,652 | +0.0% shares | Q2 2026 |
| Acorn Capital Advisors, LLCHedge fund | 16.8% | $61.6M | 1,673,420 | +0.0% shares | Q2 2026 |
| Opaleye Management Inc.Hedge fund | 4.8% | $53.0M | 1,439,996 | +0.7% shares | Q2 2026 |
| Silverarc Capital Management, LLCHedge fund | 5.3% | $47.9M | 1,301,979 | -13.4% shares | Q2 2026 |
| Mpm Bioimpact LLCHedge fund | 2.1% | $34.3M | 933,415 | -1.1% shares | Q2 2026 |
| Soleus Capital Management, L.P.Hedge fund | 1.1% | $30.5M | 829,810 | +14.1% shares | Q2 2026 |
| Boxer Capital Management, LLCHedge fund | 1.4% | $18.4M | 500,000 | +0.0% shares | Q2 2026 |
| Privium Fund Management B.V.Asset manager | 1.4% | $7.7M | 210,000 | -11.8% shares | Q2 2026 |
| Superstring Capital Management LPHedge fund | 4.4% | $7.0M | 191,313 | -50.6% shares | Q2 2026 |
| Elmind Capital, LPHedge fund | 1.1% | $4.4M | 120,000 | -45.5% shares | Q2 2026 |
| Aisling Capital Management LPHedge fund | 0.8% | $4.0M | 108,000 | +0.0% shares | Q2 2026 |
| Ally Bridge Group (NY) LLCHedge fund | 3.3% | $2.5M | 69,183 | -65.8% shares | Q2 2026 |
| Bender Robert & AssociatesInvestment manager | 0.3% | $1.4M | 34,701 | New | Q3 2026 |
| Palo Alto Investors LPHedge fund | 0.1% | $902K | 24,500 | +0.0% shares | Q2 2026 |
| Birchview Capital, LPWealth manager | 0.3% | $607K | 16,487 | — | Q2 2026 |
Each manager counts with its latest 13F (Q3 2026: 1, Q2 2026: 16). Screen URGN in the grand portfolio →
URGN stock trades by members of Congress
No member of Congress has disclosed a trade in URGN.
URGN questions and answers
Are insiders buying URGN stock?
Between Aug 1, 2026 and Oct 29, 2026, 3 URGN insiders filed 4 sales worth $3.0M on SEC Form 4, and no open-market purchases.
Which hedge funds own URGN?
17 13F filers hold URGN among their 50 largest positions, worth $612.1M combined. The biggest bets by portfolio weight are Acorn Capital Advisors, LLC (16.8%), Silverarc Capital Management, LLC (5.3%) and Kynam Capital Management, LP (5.0%). In their latest 13Fs, 1 manager opened a new position and 2 added to one.
Has Congress traded URGN?
No member of Congress has disclosed a trade in URGN.
Who is the largest holder of URGN?
Among 13F filers, Rtw Investments, LP reports the largest URGN position, $167.2M (4,543,895 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is Acorn Capital Advisors, LLC's: 16.8% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.